Showing results (31-40 of 96) with videos related to
Sort By:
Pageof 10
International Journal of Clinical and Experimental Pathology|May 13, 2014
Frequency of activating mutations in FGFR2 exon 7 in bladder tumors from patients with early-onset and regular-onset diseaseChristine Spiegelberg, Johannes Giedl, Nadine T Gaisa, et al.Journal of Cancer|December 7, 2018
<i>P53</i> Codon 72 Polymorphism and Risk for Squamous Cell Carcinoma of the Penis: A Caucasian Case-Control StudyRobert Stoehr, Rebecca Weisser, Olaf Wendler, et al.Antioxidants (Basel, Switzerland)|January 28, 2026
Intracellular Oxidant Levels Are Crucial for Cell Survival and JAK/STAT Signaling in Classical Hodgkin's LymphomaJulia Wildfeuer, Rashmi P Dheenadayalan, Svenja Hartung, et al.The American Journal of Pathology|November 18, 2019
Next-Generation Sequencing Reveals Potential Predictive Biomarkers and Targets of Therapy for Urothelial Carcinoma in Situ of the Urinary BladderStefan Garczyk, Nadina Ortiz-Brüchle, Ursula Schneider, et al.The Journal of Pathology|May 11, 2013
Lack of evidence for frequent MED12 p.L1224F mutation in prostate tumours from Caucasian patientsRobert Stoehr, Helge Taubert, Nadine T Gaisa, et al.Cancers|March 28, 2020
Pure Large Nested Variant of Urothelial Carcinoma (LNUC) Is the Prototype of an <i>FGFR3</i> Mutated Aggressive Urothelial Carcinoma with Luminal-Papillary PhenotypeVeronika Weyerer, Markus Eckstein, Eva Compérat, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 7, 2019
Left- versus right-sided hepatectomy with hilar en-bloc resection in perihilar cholangiocarcinomaJan Bednarsch, Zoltan Czigany, Isabella Lurje, et al.Pathology International|October 20, 2017
Telomerase reverse transcriptase (TERT) promoter mutations are rare in urachal cancerSebastian Thiem, Thomas Herold, Ulrich Krafft, et al.Scientific Reports|April 18, 2025
Oncolytic virotherapy provides a potent therapy option for squamous bladder cancerJulia Pannhausen, Julia Wirtz, Klaus Mantwill, et al.Virchows Archiv : an International Journal of Pathology|April 28, 2022
Heterogenous NECTIN4 expression in urothelial high-risk non-muscle-invasive bladder cancerStefan Garczyk, Stephan Degener, Felix Bischoff, et al.Pageof 10